A Multi-center, Randomized, Double-blind, Parallel Phase Ⅳ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

Inclusion Criteria:

• both male and female who are over 19-year-old

• 200mg/dl≤TG<500mg/dl

• Desired value of LDL-c

  1. very high risk < 70
  2. high risk < 100
  3. moderate risk <130
  4. low risk < 160

Exclusion Criteria:

• patient who is going to have an operation during this study
• patient who has allergy or hypersensitivity of fenofibrate
• patient who has abnormal ECG